- Home
- USLM vs APLS Comparison
USLM vs APLS Comparison
Compare USLM & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USLM
- APLS
- Stock Information
- Founded
- USLM 1948
- APLS 2009
- Country
- USLM United States
- APLS United States
- Employees
- USLM N/A
- APLS N/A
- Industry
- USLM Other Metals and Minerals
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- USLM Industrials
- APLS Health Care
- Exchange
- USLM Nasdaq
- APLS Nasdaq
- Market Cap
- USLM 2.5B
- APLS 2.3B
- IPO Year
- USLM N/A
- APLS 2017
- Fundamental
- Price
- USLM $98.99
- APLS $17.30
- Analyst Decision
- USLM
- APLS Buy
- Analyst Count
- USLM 0
- APLS 19
- Target Price
- USLM N/A
- APLS $39.06
- AVG Volume (30 Days)
- USLM 79.4K
- APLS 2.7M
- Earning Date
- USLM 04-30-2025
- APLS 05-07-2025
- Dividend Yield
- USLM 0.24%
- APLS N/A
- EPS Growth
- USLM 50.52
- APLS N/A
- EPS
- USLM 4.20
- APLS N/A
- Revenue
- USLM $337,287,000.00
- APLS $775,839,000.00
- Revenue This Year
- USLM N/A
- APLS $12.25
- Revenue Next Year
- USLM N/A
- APLS $21.08
- P/E Ratio
- USLM $23.46
- APLS N/A
- Revenue Growth
- USLM 17.83
- APLS 48.04
- 52 Week Low
- USLM $64.25
- APLS $16.65
- 52 Week High
- USLM $159.53
- APLS $43.99
- Technical
- Relative Strength Index (RSI)
- USLM 59.34
- APLS 34.14
- Support Level
- USLM $96.51
- APLS $16.65
- Resistance Level
- USLM $100.75
- APLS $20.75
- Average True Range (ATR)
- USLM 3.50
- APLS 1.09
- MACD
- USLM 0.78
- APLS 0.14
- Stochastic Oscillator
- USLM 81.40
- APLS 15.85
About USLM United States Lime & Minerals Inc.
United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime and lime slurry. It supplies its products predominantly to the construction (including highway, road, and building contractors), industrial (including paper and glass manufacturers), environmental (including municipal sanitation and water treatment facilities and flue gas treatment processes), metals (including steel producers), oil and gas services, roof shingle manufacturers and agriculture (including poultry and cattle feed producers) industries. The company operates through its Lime and Limestone Operations segment.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.